120 related articles for article (PubMed ID: 10188720)
1. Analysis of T-cell-receptor beta-chain-gene usage in peripheral-blood and tumor-infiltrating lymphocytes from human non-small-cell lung carcinomas.
Echchakir H; Asselin-Paturel C; Dorothee G; Vergnon I; Grunenwald D; Chouaib S; Mami-Chouaib F
Int J Cancer; 1999 Apr; 81(2):205-13. PubMed ID: 10188720
[TBL] [Abstract][Full Text] [Related]
2. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
3. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
Weidmann E; Elder EM; Trucco M; Lotze MT; Whiteside TL
Int J Cancer; 1993 May; 54(3):383-90. PubMed ID: 8509212
[TBL] [Abstract][Full Text] [Related]
4. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
[TBL] [Abstract][Full Text] [Related]
5. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
Weidmann E; Whiteside TL; Giorda R; Herberman RB; Trucco M
Cancer Res; 1992 Nov; 52(21):5913-20. PubMed ID: 1382847
[TBL] [Abstract][Full Text] [Related]
6. Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions.
Puisieux I; Bain C; Merrouche Y; Malacher P; Kourilsky P; Even J; Favrot M
Int J Cancer; 1996 Apr; 66(2):201-8. PubMed ID: 8603812
[TBL] [Abstract][Full Text] [Related]
7. Skewed distribution of TCR V alpha 7-bearing T cells within tumor-infiltrating lymphocytes of HLA-A24(9)-positive patients with malignant glioma.
Ebato M; Nitta T; Yagita H; Sato K; Okumura K
Immunol Lett; 1993 Dec; 39(1):53-64. PubMed ID: 8144191
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
[TBL] [Abstract][Full Text] [Related]
9. Shared amino acid sequences in the ND beta N and N alpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma.
Ebato M; Nitta T; Yagita H; Sato K; Okumura K
Eur J Immunol; 1994 Dec; 24(12):2987-92. PubMed ID: 7805726
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients.
Asselin-Paturel C; Echchakir H; Carayol G; Gay F; Opolon P; Grunenwald D; Chouaib S; Mami-Chouaib F
Int J Cancer; 1998 Jul; 77(1):7-12. PubMed ID: 9639386
[TBL] [Abstract][Full Text] [Related]
11. Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.
Shah P; Forget MA; Frank ML; Jiang P; Sakellariou-Thompson D; Federico L; Khairullah R; Neutzler CA; Wistuba I; Chow CB; Long Y; Fujimoto J; Lin SY; Maitra A; Negrao MV; Mitchell KG; Weissferdt A; Vaporciyan AA; Cascone T; Roth JA; Zhang J; Sepesi B; Gibbons DL; Heymach JV; Haymaker CL; McGrail DJ; Reuben A; Bernatchez C
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35110355
[TBL] [Abstract][Full Text] [Related]
12. Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma.
Dorothée G; Echchakir H; Le Maux Chansac B; Vergnon I; El Hage F; Moretta A; Bensussan A; Chouaib S; Mami-Chouaib F
Oncogene; 2003 Oct; 22(46):7192-8. PubMed ID: 14562047
[TBL] [Abstract][Full Text] [Related]
13. High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma.
Roussel E; Gingras MC; Grimm EA; Roth JA
Cancer Immunol Immunother; 1995 Jul; 41(1):1-9. PubMed ID: 7641214
[TBL] [Abstract][Full Text] [Related]
14. T cell receptor V alpha and V beta gene usage by tumour-infiltrating lymphocytes in oral squamous cell carcinoma.
Mouri T; Nakamura S; Ohyama Y; Matsuzaki G; Shinohara M; Kishihara K; Hiroki A; Oka M; Shirasuna K; Nomoto K
Cancer Immunol Immunother; 1996 Sep; 43(1):10-8. PubMed ID: 8917630
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
[TBL] [Abstract][Full Text] [Related]
16. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
Zeuthen J; Birck A; Straten PT
Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
[TBL] [Abstract][Full Text] [Related]
17. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
Ikeda H; Sato N; Matsuura A; Kikuchi K
Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
[TBL] [Abstract][Full Text] [Related]
18. Dissociation between T helper type 1 and type 2 differentiation and cytokine production in tumor-infiltrating lymphocytes in patients with lung cancer.
Ito N; Nakamura H; Metsugi H; Ohgi S
Surg Today; 2001; 31(5):390-4. PubMed ID: 11381500
[TBL] [Abstract][Full Text] [Related]
19. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
20. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.
Choudhary A; Davodeau F; Moreau A; Peyrat MA; Bonneville M; Jotereau F
J Immunol; 1995 Apr; 154(8):3932-40. PubMed ID: 7706731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
